Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Final efficacy, safety and biomarker results of the phase 2b/3 randomized, double-blinded, placebo-controlled early trial of atabecestat in preclinical alzheimer’s disease

David Henley,Reisa A. Sperling,Paul S. Aisen,Rema Raman,Michael C. Donohue,Karin Ernstrom,Yingqi Shi,Keith Karcher,Nandini Raghavan,Yevgen Tymofyeyev,Robert Brashear,Gerald P. Novak,John Thipphawong,Ziad Saad,Hartmuth C. Kolb,Gary Romano

Alzheimers & Dementia（2019）

Cited 1|Views53
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined